Tagged With: medical
Medical Marijuana Research Act of 2017
Representatives Andy Harris, M.D. (R-MD-01), Earl Blumenauer (D-OR-03), H. Morgan Griffith (R-VA-09), and Zoe Lofgren (D-CA-19) introduced H.R. 3391: The Medical Marijuana Research Act of 2017. This Act amends the federal law to facilitate clinical investigations involving the use of cannabis and cannabis-derived products. As you may know, there are many benefits to medical cannabis. … Continue reading
Vote Expected Tomorrow On Medical Marijuana
Tomorrow, the Senate Appropriations Committee will have to decide: Will they protect our nation’s 2 million lawful medical marijuana patients or subject them to the wrath of Attorney General Jeff Sessions? The amendment they will be debating, known as Rohrabacher-Blumenauer, simply prevents the United States Department of Justice from spending any of our tax dollars … Continue reading
Harris Introduces Bipartisan Bill Facilitating Medical Marijuana Research
On July 25, Representatives Andy Harris, M.D. (R-MD-01), Earl Blumenauer (D-OR-03), H. Morgan Griffith (R-VA-09), and Zoe Lofgren (D-CA-19) introduced H.R. 3391 (the Medical Marijuana Research Act of 2017). The Medical Marijuana Research Act of 2017 amends the Controlled Substances Act to make marijuana accessible for use by qualified marijuana researchers for medical purposes, and … Continue reading
Senate Committee Passes Amendment To Protect Medical Marijuana
Senator Patrick Leahy Today, Senator Patrick Leahy (D-VT) successfully offered and passed the Rohrabacher-Blumenauer amendment in the Senate Appropriations Committee to protect lawful medical marijuana programs from the Department of Justice. Initially enacted by Congress in 2014, the amendment maintains that federal funds cannot be used to prevent states from “implementing their own state laws that … Continue reading
Federal: Continue To Protect Lawful Medical Marijuana Programs
Senate Update: The Senate Appropriations Committee is expected to consider the Rohrabacher-Blumenauer amendment on Thursday, July 27th. House Update: The House Appropriations Committee released its 2018 Commerce, Justice, Science (CJS) Appropriations bill, which determines the funding levels for numerous federal agencies, including the Department of Justice. Predictably, the bill does not include language — known as … Continue reading
Ask Governor Abbott to add medical cannabis to the special session
During the regular legislative session, more than half of the Texas House, including three out of four physicians, signed onto a bill that would have made the Compassionate Use Program more inclusive. They answered the cries of patients and caregivers who know the benefits cannabis can provide. All at once, you can tell your legislators … Continue reading
Texas: Amendment To Protect Doctors Right To Recommend Medical Marijuana Pending
In 2015, the Texas Legislature passed the Compassionate Use Program, allowing those with intractable epilepsy to access medical cannabis to treat their seizures. Because of cannabis’ status as a Schedule I drug under Federal law, it cannot be “prescribed.” It can, however, be recommended and patients can be formally certified by doctors through the state … Continue reading
Texas: Amendment To Protect Doctors Right To Recommend Medical Marijuana Pending
In 2015, the Texas Legislature passed the Compassionate Use Program, allowing those with intractable epilepsy to access medical cannabis to treat their seizures. Because of cannabis’ status as a Schedule I drug under Federal law, it cannot be “prescribed.” It can, however, be recommended and patients can be formally certified by doctors through the state … Continue reading
Massachusetts: Medical Marijuana Patients’ Afforded Workplace Protections, High Court Rules
State-registered medical cannabis patients may sue a private employer for discrimination if they are fired for their off-the-job marijuana use, according to a first in the nation ruling issued today by the Massachusetts Supreme Judicial Court. Opining for the court, Chief Justice Ralph Gants determined that it is “not facially unreasonable” for employers to make … Continue reading
